Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Their medicines are helping millions of patients around the world in their fight against cancer, cardiovascular disease, hepatitis B, HIV/AIDS and rheumatoid arthritis. Over the past decade, Bristol-Myers Squibb has delivered 14 new products to patients with serious diseases, four of which are biologic products. Additional biologic compounds, as well as scores of other investigational medicines, are advancing through the development pipeline. Bristol-Myers Squibb is recognized as having one of the most productive R&D pipelines in the industry. As a BioPharma leader, they believe what sets them apart is a commitment to helping patients prevail over serious diseases and their focus on finding innovative medicines to combat those diseases. Generating new ideas and thinking differently are at the heart of everything Bristol-Myers Squibb does: making a difference in the lives of patients.